Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer.

Article Details

Citation

Copy to clipboard

Deng Y, Sychterz C, Suttle AB, Dar MM, Bershas D, Negash K, Qian Y, Chen EP, Gorycki PD, Ho MY

Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer.

Xenobiotica. 2013 May;43(5):443-53. doi: 10.3109/00498254.2012.734642. Epub 2012 Nov 16.

PubMed ID

23548165 [ View in PubMed

]

Abstract

1. Pazopanib (Votrient) is an oral tyrosine kinase inhibitor that was recently approved for the treatment of renal cell carcinoma and soft tissue sarcoma. 2. In this two-part study, we investigated the metabolism, disposition of [(14)C]pazopanib, and the oral bioavailability of pazopanib tablets in patients with advanced cancer. 3. In part A, three men each received a single oral dose of [(14)C]pazopanib in suspension (400 mg, 70 microCi). Pazopanib was the predominant drug-related component in circulation. Two metabolites derived from hydroxylation and one from N-demethylation were also circulating, but were minor, each accounting for <5% of plasma radioactivity. Faecal elimination predominated, accounting for 82.2% of the administered radio-dose, with negligible renal elimination (2.6% of dose). Pazopanib was primarily excreted as the unchanged drug in faeces (67% of dose). 4. In part B, seven additional patients received a single intravenous administration of 5 mg pazopanib (day 1) followed by oral administration of 800 mg pazopanib tablet once daily for 26 days (days 3 or 5-28). In the three evaluable patients from part B, pazopanib had a slow plasma clearance and a small volume of distribution. The absolute oral bioavailability of the 800 mg pazopanib tablet ranged from 14% to 39%.

DrugBank Data that Cites this Article

Drugs

Pazopanib

Drug Transporters

Drug	Transporter	Kind	Organism	Pharmacological Action	Actions
Pazopanib	ATP-binding cassette sub-family G member 2	Protein	Humans	Unknown	Substrate	Details
Pazopanib	P-glycoprotein 1	Protein	Humans	Unknown	Substrate	Details